Taught a lesson by taut skin

A 45 year old man with a history of ulcerative colitis presented to his general practitioner because of Raynaud’s phenomenon and itchy tight skin that had affected his hands and elbows bilaterally over the preceding few months. He was referred to a rheumatologist, who performed a series of immunological tests. The results included a positive antinuclear antibody staining pattern on immunoflourescence, with anti-RNA polymerase III antibodies identified on further testing. Tests for anti-centromere and anti-topoisomerase I (anti-Scl 70) antibodies were negative. The rheumatologist diagnosed a systemic connective tissue disorder. When the skin symptoms worsened over the next few weeks the patient started to use over the counter ibuprofen to ease the pain associated with his tight skin. He subsequently presented to the emergency department with fatigue. His blood pressure was found to be 210/120 mm Hg. In addition to the skin abnormalities, bibasal fine inspiratory crepitations were detected on physical examination. Routine laboratory testing showed haemoglobin 75 g/L (reference range 130-180), creatinine 475 µmol/L (80 µmol/L one month previously (80-110), and lactate dehydrogenase 357 U/L (70-250). Electrocardiography showed T wave inversion in the lateral leads. He was excreting 1.15 g of protein in his urine per 24 hours and haematuria was detected on dipstick urinalysis. ### What is the diagnosis? #### Short answer Scleroderma renal crisis, which results in a hypertensive emergency.1 #### Long answer Our patient had diffuse cutaneous scleroderma. Figures 1⇓ and 2⇓ show taut shiny skin on his forearm and hands, with areas of hypopigmentation on the extensor surfaces. The skin was so tight that he developed contractures at the elbows (fig 1 shows the position of maximal …

[1]  D. Wuttge,et al.  Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor , 2012, Scandinavian journal of rheumatology.

[2]  L. Mouthon,et al.  Scleroderma Renal Crisis: A Rare but Severe Complication of Systemic Sclerosis , 2011, Clinical reviews in allergy & immunology.

[3]  M. Mayes,et al.  HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis. , 2011, Arthritis and rheumatism.

[4]  L. Mouthon,et al.  Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients , 2007, Annals of the rheumatic diseases.

[5]  W. Whittier,et al.  Renal biopsy: update , 2004, Current opinion in nephrology and hypertension.

[6]  Richard W. Martin,et al.  Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial. , 2002, Arthritis and rheumatism.

[7]  T. Medsger,et al.  Long-Term Outcomes of Scleroderma Renal Crisis , 2000, Annals of Internal Medicine.

[8]  T. Medsger,et al.  Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. , 1998, Arthritis and rheumatism.

[9]  A. Silman,et al.  Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. , 1996, British journal of rheumatology.

[10]  V. Steen Scleroderma renal crisis. , 1996, Rheumatic diseases clinics of North America.

[11]  J. Donohoe Scleroderma and the kidney. , 1992, Kidney international.

[12]  J. Costantino,et al.  Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. , 1990, Annals of internal medicine.

[13]  T. Medsger,et al.  Normotensive renal failure in systemic sclerosis. , 1989, Arthritis and rheumatism.

[14]  T. Medsger,et al.  Factors Predicting Development of Renal Involvement in Progressive Systemic Sclerosis , 1984 .

[15]  T. Medsger,et al.  Factors predicting development of renal involvement in progressive systemic sclerosis. , 1984, The American journal of medicine.

[16]  T. Medsger,et al.  Hypertension and Renal Failure (Scleroderma Renal Crisis) in Progressive Systemic Sclerosis: REVIEW OF A 25‐YEAR EXPERIENCE WITH 68 CASES , 1983, Medicine.

[17]  A. Masi,et al.  Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients. , 1971, Annals of internal medicine.

[18]  Tien Yin Wong,et al.  Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. , 2005, British medical bulletin.

[19]  C. Kitiyakara,et al.  Malignant hypertension and hypertensive emergencies. , 1998, Journal of the American Society of Nephrology : JASN.

[20]  C. Denton,et al.  Acute renal failure occurring in scleroderma treated with cyclosporin A: a report of three cases. , 1994, British journal of rheumatology.

[21]  A. Nissenson,et al.  Outcome of end-stage renal disease in patients with rare causes of renal failure. III. Systemic/vascular disorders. , 1990, The Quarterly journal of medicine.